NEUROCENTRX PHARMA LIMITED
C/O MORTON FRASER LLP 2 LISTER SQUARE, QUARTERMILE TWO, EDINBURGH  EH3 9GL- Active
- Private Limited Company
- Company No. SC454814
- Last Updated: 01 Mar 2024
Company Profile
NEUROCENTRX PHARMA LIMITED was incorporated on Thursday, July 18, 2013 as a Private Limited Company with registered address in EDINBURGH. NEUROCENTRX PHARMA LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 11 years 3 months and 23 days.
Name | NEUROCENTRX PHARMA LIMITED |
---|---|
Company number | SC454814 |
Company type | Private Limited Company |
Incorporation date | 18 Jul 2013 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
C/O MORTON FRASER LLP 2 LISTER SQUARE QUARTERMILE TWO EDINBURGH EH3 9GL |
---|---|
Country Of Origin | SCOTLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Fraser Stuart Lusty Nationality: British |
Dates: Wednesday, April 6, 2016 - Wednesday, April 6, 2016
significant influence or control
|
Scottish Enterprise Waterloo Street, G2 6HQ |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Equity Gap Limited St. Vincent Street, G2 5RZ |
Dates: Wednesday, April 6, 2016 - Tuesday, November 12, 2019
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 October |
Next annual accounts due | 31 July 2024, (-102 days left) |
Latest accounts | 31 October 2022 |
Next confirmation statement due | 15 August 2016 |
Last confirmation statement dated | 18 July 2015 |
Mortgages
No mortgages have been registered against NEUROCENTRX PHARMA LIMITED.
Previous Names
Name | Change Date |
---|---|
NEUROCENTRX PHARMA LIMITED | 18 Jul 2013 |